Morphology of the Inner Structure of the Hippocampal Formation in Alzheimer Disease

References

1. ↵
   Mohs RC, Doody RS, Morris JC, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001;57:481–488

   Abstract/FREE Full Text
2. Winblad B, Engedal K, Soininen H, et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001;57:489–495

   Abstract/FREE Full Text
3. ↵
   Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Open-label, multicenter, phase 3 extension study of the safety and efficacy of doneprzil in patients with Alzheimer disease. Arch Neurol 2001;58:427–433

   CrossRefPubMedWeb of Science
4. ↵
   Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994;15:929–937

   Abstract/FREE Full Text
5. Dickerson BC, Goncharova I, Sullivan MP, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease. Neurobiol Aging 2001;22:747–754

   CrossRefPubMedWeb of Science
6. Du AT, Schuff N, Amend D, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2001;71:441–447

   Abstract/FREE Full Text
7. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer’s disease: a longitudinal MRI study. Brain 1996;119:2001–2007

   Abstract/FREE Full Text
8. Smith CD, Malcein M, Meurer K, Schmitt FA, Markesbery WR, Pettigrew LC. MRI temporal lobe volume measures and neuropsychologic function in Alzheimer’s disease. J Neuroimaging 1999;9:2–9

   PubMedWeb of Science
9. ↵
   Petersen RC, Jack CR, Xu YC, et al. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000;54:581–587

   Abstract/FREE Full Text
10. Xu Y, Jack CR, O’Brien PC, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000;54:1760–1767

    Abstract/FREE Full Text
11. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Jolesz F, Jones K. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 2002;58:1188–1196

    Abstract/FREE Full Text
12. ↵
    Hasboun D, Chantome M, Zouaoui A, et al. MR determination of hippocampal volume: comparison of three methods. AJNR Am J Neuroradiol 1996;17:1091–1098

    Abstract
13. ↵
    Moseley ME, Cohen Y, Kcharczyk J, et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176:439–445

    PubMedWeb of Science
14. Hosoya T, Adachi M, Yamaguchi K, Haku T. MRI anatomy of white matter layers around the trigone of the lateral ventricle. Neuroradiology 1998;40:477–482

    PubMed
15. Adachi M, Hosoya T, Haku T, et al. Evaluation of the substantia nigra in patients with parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging. AJNR Am J Neuroradiol 1999;20:1500–1506

    Abstract/FREE Full Text
16. ↵
    Adachi M, Hosoya T, Yamaguchi K, et al. Diffusion-weighted and T2-weighted MRI of the transverse pontine fibres in spinpcerebellar degeneration. Neuroradiology 2000;42:803–809

    CrossRefPubMedWeb of Science
17. ↵
    McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944

    Abstract/FREE Full Text
18. ↵
    Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189–198

    CrossRefPubMedWeb of Science
19. ↵
    Stejskal EO, Tenner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288–292

    CrossRef
20. ↵
    Mizutani T, Kasahara M. Degeneration of the intrahippocampal routes of the perforant and alvear pathways in senile dementia of Alzheimer type. Neurosci Lett 1995;184:141–144

    CrossRefPubMedWeb of Science
21. Mizutani T, Kasahara M. Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia. Neurosci Lett 1997;222:119–122

    CrossRefPubMedWeb of Science
22. Mizutani T, Shimada H. Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 1992;108:168–177

    CrossRefPubMedWeb of Science
23. ↵
    Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer’s disease. Ann Neurol 1986;20:472–481

    CrossRefPubMedWeb of Science
24. Price JL, Ko AI, Wada MJ, et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001;58:1395–1402

    CrossRefPubMedWeb of Science
25. Bobinski M, de Leon MJ, Tarnawski M, et al. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res 1998;805:267–269

    CrossRefPubMedWeb of Science
26. ↵
    Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer’s disease. Prog Brain Res 1990;83:445–457

    CrossRefPubMedWeb of Science
27. ↵
    Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama K. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. AJNR Am J Neuroradiol 2002;23:1747–1756

    Abstract/FREE Full Text